Lexicon Pharmaceuticals LXRX Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's common stock, shares issued (in shares)?
- Lexicon Pharmaceuticals (LXRX) reported common stock, shares issued (in shares) of $425.71M in Q1 2026.
- How has Lexicon Pharmaceuticals's common stock, shares issued (in shares) changed year-over-year?
- Lexicon Pharmaceuticals's common stock, shares issued (in shares) increased by 16.5% year-over-year, from $365.56M to $425.71M.
- What is the long-term trend for Lexicon Pharmaceuticals's common stock, shares issued (in shares)?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's common stock, shares issued (in shares) has grown at a 20.8% compound annual growth rate (CAGR), from $142.29M to $365.85M.